FIGURE

Figure 5

ID

ZDB-FIG-230814-243

Publication

De la Cruz et al., 2023 - Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart

Other Figures

All Figure Page

Back to All Figure Page

Figure 5

PUFA analogues do not shorten the zebrafish AP in LQT2 drug-induced conditions. (A) Representative zebrafish AP traces before (black) and after sequentially applying E4031 (10 µM, red) and E4031/DHA-Gly (10 µM/20 µM, dark green). (B) ΔAPD80 (%) measured at different recording times (10, 20, and 30 min after application of the combination drug/PUFA analogue). The E4031 recording, measured at 30 min, was used as the control condition. (C) ΔAPD (%) produced by the combination of drug/PUFA analogue measured for the APD25, APD50, APD80, and APD90. (D) Effect of the combination of drug/PUFA analogue on phase 3 of the AP. APD80–APD25 in E4031 (control conditions) and after E4031/DHA-Gly application. (E–H) The same as (A–D) but for the combination E4031/LIN-Gly (10 µM/20 µM) (mean ± SEM; ^#p <0.05 vs. E4031 condition). Each symbol in panels D and H represent data from a different experiment.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.